Day 1: Tuesday, October 27, 2026 5.25 CME
Workshop A1: Tips from Experts on Using an AID System: A Case-Based Journey
1.25 CE
Nicholas Argento, MD, FACE
Maryland Endocrine and Diabetes Center, Columbia, MD, USA
08:00
Starting an AID System
Veronica Brady, PhD
University of Texas Health Cizik School of Nursing and MD Anderson Cancer Center, Houston, TX USA
08:20
Products and Algorithms
David Ahn, MD
Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USA
08:40
Managing an AID System
Jo Ellen Condon, BS
Diabetes EmpowerMENT, LLC, Nourish, Annapolis, MD, USA
09:00
Panel Discussion
09:15
Q+A
BREAK
09:20
Workshop A2: Hospital Diabetes Technology
1.75 CE
Madhu Subhas, MD
Omaha VA Medical Center, Omaha, NE, USA
09:50
Software for Insulin Dosing
Guillermo Umpierrez, MD
Emory University, Atlanta, GA, USA
10:12
CGMs and AID Systems
Elias Spanakis, MD
University of Maryland, Baltimore, MD, USA
10:34
iCoDE2 for Interoperability
Juan Espinoza, MD
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA
10:56
CGM at Discharge
Jane Seley, DNP MPH
Weill Cornell Medicine, New York, NY, USA
11:18
Q+A
LUNCH
11:30
Workshop A3: AI for Diabetes Management
1.5 CE
Ahmed Metwally, PhD
Google, Mountain View, CA, USA
13:10
Overview of AI for Diabetes
Juan Espinoza, MD
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA
13:32
LLM Dietary Chat Validation: Assessing and Improving the Accuracy of LLM-Based Chat Interactions for Patient Dietary Feedback
Kayo Waki, PhD
Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
13:54
Natural Language Processing (NLP)
Nestoras Mathioudakis, MD, MHS
Division of Endocrinology & Metabolism, Department of Medicine, The Johns Hopkins Hospital, Baltimore, MD, USA
14:16
The Dark Side of AI
Shahid Shah, MS
Netspective Foundation Inc., Silver Spring, MD, USA
14:38
Q+A
BREAK
14:45
Workshop A4: Insulin Delivery Technology
1.25 CE
Cecilia Lansang, MD, MPH
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic Foundation, Cleveland, OH, USA
Suzanne Lohnes, FNP-BC
San Ysidro Health Clinic, Chula Vista, CA, USA
15:15
FITTER for Insulin Delivery
Jane Seley, DNP MPH
Weill Cornell Medicine, New York, NY, USA
15:40
Smart Pens
Julia Mader, MD
Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
16:05
AID for Type 2 Diabetes
Viral Shah, MD
Indiana University School of Medicine, Indianapolis, IN, USA
16:30
Q+A
Workshop B1: Novel Noninvasive and Ketone Monitoring Technology
No CE
Peter Rule, MBA
Pacific Research Institute, San Francisco, CA, USA
Jeon Woong Kang, PhD
Massachusetts Institute of Technology, Cambridge, MA, USA
08:00
Breath Glucose Monitoring
Frank Flacke, PhD
Flacke Consulting GmbH, Mainz, Germany
08:15
Continuous Ketone Monitoring
Richard Bergenstal, MD
International Diabetes Center at Park Nicollet, Minneapolis, MN, USA
08:30
EEG to Measure Glycemia
Casey Halpern, MD
SynchNeuro, Inc, Philadelphia, PA, USA
08:45
Noninvasive Blood Pressure Monitoring
Tammy Brady, MD, PhD, MHS
Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC, USA
09:00
Noninvasive Voice Monitoring
Jeffrey Joseph, DO
Thomas Jefferson University and Hospital, Philadelphia, PA, USA
09:15
Q+A
BREAK
09:20
Workshop B2: Standards for Evaluating CGM Performance
1.5 CE
Kong Chen, PhD
National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
09:50
IEEE 2621 Cybersecurity Standard for Diabetes Devices
Ravi Subramaniam, BS, MBA
IEEE Standards Association, Piscataway, NJ, USA
10:05
Application of Standards for Regulating CGM Technology
Emily Dunkelberger, PhD
U.S. Food and Drug Administration, Silver Spring, MD, USA
10:20
IFCC Working Group Guideline for CGMs
Guido Freckmann, MD
Institut für Diabtes-Technologie Ulm GmbH, Ulm, Germany
10:35
IEC/TC 62 for Continuous Glucose Monitors
Huilin Zhou, BS
IEC TC 62D, Shanghai, China
10:50
DTS CGM Performance Guideline
Marisa Cruz, MD
Fogline Digital Health, Moss Beach, CA, USA; UCSF, San Francisco, CA, USA
11:05
DTS CGM Performance Guideline
David Sacks, MBChB, FRCPath
George Washington University, Washington, DC, USA
11:20
Q+A
LUNCH
11:30
Workshop B3: CGM Data Analysis
1.5 CE
Robert Bem, MD, PhD, MHA
Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
Eslam Montaser, PhD
Indiana University School of Medicine, Indianapolis, IN, USA
13:10
New Methods for CGM Data Analysis
Boris Kovatchev, PhD
University of Virginia, Center for Diabetes Technology, Charlottesville, VA, USA
13:32
Glucodensity Predicts Diabetes Outcomes
Marcos Matabuena, PhD
Mohamed bin Zayed University of Artificial Intelligence, Abu Dhabi, United Arab Emirates
13:54
AI to Distinguish Diabetes Phenotypes
Michael Snyder, PhD
Stanford University School of Medicine, Palo Alto, CA, USA
14:16
New Algorithms for Analyzing CGM Data
Peter Calhoun, PhD
Jaeb Center for Health Research, Tampa, FL, USA
14:38
Q+A
BREAK
14:45
Workshop B4: Debate - Open Source Software for Diabetes Devices
No CE
Grazia Aleppo, MD
Northwestern University, Chicago, IL, USA
15:15
Intellectual Property Protection of Published Data and Code for Diabetes Devices
Brian Novak, PhD, JD
K&L Gates LLP, Irvine, CA, USA
15:30
Open Source Software
Kelly Watson
Tidepool, Palo Alto, CA, USA
15:45
DEBATE: 100% Open Access vs. <100% Open Access:
15:45
100% Open Access
Rayhan Lal, MD
Stanford University, Stanford, CA, USA
15:55
<100% Open Access
Shahid Shah, MS
Netspective Foundation Inc., Silver Spring, MD, USA
16:05
Rebuttal in Support of 100% Open Access
Rayhan Lal, MD
Stanford University, Stanford, CA, USA
16:10
Rebuttal in Support of <100% Open Access
Shahid Shah, MS
Netspective Foundation Inc., Silver Spring, MD, USA
16:15
Open Access Legal Issues
Jason Johnson, JD
Crowell & Moring, New York, NY, USA
16:30
Q+A
Poster Session
16:35
Day 2: Wednesday, October 28, 2026 6 CME
Welcome
No CE
08:00
Welcoming Remarks
David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Sutter Health Research Institute, Emeryville, CA, USA; Department of Diabetes & Endocrinology, Sutter Mills Peninsula Medical Center, San Mateo, CA, USA
Keynote Speaker
0.5 CE
David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Sutter Health Research Institute, Emeryville, CA, USA; Department of Diabetes & Endocrinology, Sutter Mills Peninsula Medical Center, San Mateo, CA, USA
08:10
Regulation of Artificial Intelligence and Digital Health in Diabetes Devices
Courtney Lias, PhD
U.S. Food and Drug Administration, Silver Spring, MD, USA
Session 1: The 2026 ADA Standards of Care
0.75 CE
Joshua Neumiller, PharmD
American Diabetes Association, Spokane, WA, USA
08:35
The 2026 ADA Standards of Care
Grazia Aleppo, MD
Northwestern University, Chicago, IL, USA
09:05
Q&A
BREAK
09:20
Session 2: Future of Diabetes Technology
1 CE
David Kerr, MBChB, DM
Sutter Health Research Institute, Santa Barbara, CA, USA
Lutz Heinemann, PhD
Science Consulting in Diabetes GmbH, Düsseldorf, Germany
10:05
Panel Discussion
Derek Brandt
Diabetes Center Berne, Berne, Switzerland
Sean Sullivan, PhD
Helmsley Charitable Trust, New York, NY, USA
Erich Huang, MD, PhD
Advocate Health, Charlotte, NC, USA
Osagie Ebekozien, MD, MPH, CPHQ
American Diabetes Association, Arlington, VA, USA
Session 3: Special Lecture: Technology for Healthy Behavior
0.25 CE
Sonali Thosani, MD
Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, USA.
11:10
Wearables for Modifying Behavior
David Kerr, MBChB, DM
Sutter Health Research Institute, Santa Barbara, CA, USA
11:25
Q+A
LUNCH
11:30
Session 4A: Continuous Glucose Monitoring and HbA1c Data Interpretation
1.5 CE
John Melish, MD
University of Hawaii, Honolulu, HI, USA
Viral Shah, MD
Indiana University School of Medicine, Indianapolis, IN, USA
13:10
Using the AGP to Manage Diabetes
Richard Bergenstal, MD
International Diabetes Center at Park Nicollet, Minneapolis, MN, USA
13:30
New Metrics for Better Analyzing Glycemia for Outpatient and Inpatient Diabetes Management
Erin Tallon, PhD
Childrens Mercy Hospital, Kansas City, MO, USA
13:50
CGM in People without Diabetes
Halis Akturk, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, CO, USA
14:10
Beyond HbA1c: CGM-Derived Metrics for Tracking Type 1 Diabetes Progression
Eslam Montaser, PhD
Indiana University School of Medicine, Indianapolis, IN, USA
14:30
Q+A
Session 4B: New Technology from Industry
No CE
Alberto Gutierrez, PhD
NDA Partners LLC, Bethesda, MD, USA
Emma Zhang, BA
Diabetes Technology Society, Burlingame, CA, USA
13:10
New Technology from Abbott
Matthew Bates
Abbott, Alameda, CA, USA
13:20
New Technology from Dexcom
Jessica Castle, MD
Dexcom, Inc., San Diego, CA, USA
13:30
New Technology from Medtronic
Robert Vigersky, MD
MiniMed, Inc., Northridge, CA, USA
13:40
New Technology from Roche
Kara Shugars, MBA, RD, CDCES
Roche, Indianapolis, IN, USA
13:50
iCan CGM: A New User Choice Worldwide
Frank Flacke, PhD
Flacke Consulting GmbH, Mainz, Germany
14:00
New Technology from Biolinq
Rebecca Gottlieb, PhD
Biolinq, San Diego, CA, USA
14:10
Q+A
BREAK
14:40
Session 5A: New Drugs and Drug Delivery Systems
1.5 CE
Nicole Spartano, PhD
Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA
15:10
Novel Insulin Pumps
Halis Akturk, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, CO, USA
15:30
Ultra Long-Acting Insulin
Grazia Aleppo, MD
Northwestern University, Chicago, IL, USA
15:50
Emerging Drugs in the Pipeline for Diabetes and Obesity
Stephen Clement, MD
Division of Endocrinology, Inova Fairfax Hospital, Falls Church, VA, USA
16:10
Endoscopic Therapies for Diabetes and Obesity
Jennifer Phan, MD
Hoag Digestive Health Institute, Newport Beach, CA, USA
16:30
Q+A
Session 5B: AID Systems for Fully Closed Loop
1.5 CE
Jeffrey Joseph, DO
Thomas Jefferson University and Hospital, Philadelphia, PA, USA
Thomas Pieber, MD
Medical University of Graz, Graz, Austria
15:10
Artificial Pancreas Award
David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Sutter Health Research Institute, Emeryville, CA, USA; Department of Diabetes & Endocrinology, Sutter Mills Peninsula Medical Center, San Mateo, CA, USA
15:15
Fully Closed-Loop Control
Boris Kovatchev, PhD
University of Virginia, Center for Diabetes Technology, Charlottesville, VA, USA
15:33
Fully Closed-Loop Control in Children
Roman Hovorka, PhD
University of Cambridge, Cambridge, United Kingdom
15:51
Algorithms for Fully Closed-Loop Control
Ali Cinar, PhD
Illinois Institute of Technology, Chicago, IL, USA
16:09
AI for Fully Closed-Loop Control
Peter Jacobs, PhD
Oregon State University, Corvallis, OR, USA
16:27
Q+A
Poster Session
16:35
Day 3: Thursday, October 29, 2026 3.75 CME
Session 6A: Technology for Pregnancy and Pediatrics
1.25 CE
Marisa Cruz, MD
Fogline Digital Health, Moss Beach, CA, USA; UCSF, San Francisco, CA, USA
08:00
CGM in Pregnancy
Olivia Docter, DNP, APRN, WHNP-BC, CDCES
University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, CO, USA
08:30
Digital Health for Pediatrics
Risa Wolf, MD
Johns Hopkins Medicine, Baltimore, MD, USA
09:00
Q+A
Session 6B: AI for Analyzing CGM Data
1.25 CE
Boris Kovatchev, PhD
University of Virginia, Center for Diabetes Technology, Charlottesville, VA, USA
08:00
TBD
Mohammedreza Ganji, MS
University of Virginia, Center for Diabetes Technology, Charlottesville, VA, USA
08:15
Diagnosing Diabetes with AI
Michael Snyder, PhD
Stanford University School of Medicine, Palo Alto, CA, USA
08:30
Using LLMs to Interpret CGM Data
Elizabeth Healey, PhD
Boston Children's Hospital, Boston, MA, USA
08:45
AI to Analyze CGM Data
Andrea Facchinetti, PhD
University of Padova, Padova, Italy
09:00
Q+A
Session 7A: Reimbursement for Diabetes Technology
1 CE
Ashley DuNova, BA
Diabetes Technology Society, Burlingame, CA, USA
09:10
Current Status of Reimbursement for Diabetes Technology
Lisa Murdock
American Diabetes Association, Arlington, VA, USA
09:35
Reducing the Friction of Reimbursement for Diabetes Technology
Ashley Pickering Brown, MSN, RN, CNP, AGPCNP-C, CDCES
Joslin Diabetes Center, Boston, MA, USA
10:00
Q+A
Session 7B: Multianalyte Monitoring
No CE
Guido Freckmann, MD
Institut für Diabtes-Technologie Ulm GmbH, Ulm, Germany
09:10
Multianalyte Monitoring
Joseph Wang, PhD
Department of Nanoengineering, University of California, San Diego, La Jolla, CA, USA
09:28
Aptamer Technology to Measure Phenylalanine as a Weight Loss Marker
Jared Tangney, PhD
Biolinq, Inc, San Diego, CA, USA
09:46
Prediabetes: Time to Change the Terminology
Viral Shah, MD
Indiana University School of Medicine, Indianapolis, IN, USA
10:04
Q+A
BREAK
10:10
Session 8A: New Applications for Digital Health
No CE
Souptik Barua, PhD
NYU Grossman School of Medicine, New York, NY, USA
10:40
Mobile App Technology for Diabetes
David Ahn, MD
Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USA
10:55
Digital Health Technology for Diabetic Foot Ulcers
Lucian Feraru, DPM
Adventist Health White Memorial, Pomona, CA, USA
11:10
WEAR-ME Study for Diagnosing Insulin Resistance
Ahmed Metwally, PhD
Google, Mountain View, CA, USA
11:25
Q+A
Session 8B: Glucose Contest for Algorithms Predicting CGM Values
No CE
Tao Wang, PhD
Stanford University, Palo Alto, CA, USA
10:40
Panel Discussion
Sam Royston, MS
Replica Health, New York, NY, USA
Tao Wang, PhD
Stanford University, Palo Alto, CA, USA
Elizabeth Healey, PhD
Boston Children's Hospital, Boston, MA, USA
Eleonora Maria Aiello, PhD
University of Pavia, Pavia, Italy
Yao Qin, PhD
University of California, Santa Barbara, Santa Barbara, CA, USA
Kiran Mehta, PhD
Diabetes Technology Society, Burlingame, CA, USA
11:25
Q+A
LUNCH
11:30
Session 9A: Abstracts 1
No CE
Benjamin Lalani, BS
Harvard Medical School, Boston, MA, USA
Jane Seley, DNP MPH
Weill Cornell Medicine, New York, NY, USA
13:10
Student Research Awards
David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Sutter Health Research Institute, Emeryville, CA, USA; Department of Diabetes & Endocrinology, Sutter Mills Peninsula Medical Center, San Mateo, CA, USA
13:15
Are Ultra-Rapid-Acting Insulin Analogs Associated With Better Glycemic Outcomes in Adults With Type 1 Diabetes Using Automated Insulin Delivery Systems? A Real-World Cohort Study
David Vávra, MD
Institute of Clinical and Experimental Medicine, Prague, Czech Republic
13:25
Continuous Glucose Monitoring Metrics Predict ≥40% eGFR Decline Among Adults With Type 1 and Type 2 Diabetes
Bowen Zhang, MS
UCLA, Los Angeles, CA, USA
13:35
Effectiveness of Automated Insulin Delivery Systems During Commercial Air Travel in Adults With Type 1 Diabetes: A Preliminary Analysis of a Real-World Study
Omaima El-Hakouni, MSc
Medical University of Graz, Graz, Styria, Austria
13:45
Glycemia Risk Index Identifies Residual Glycemic Risk Despite Achievement of Recommended Glycemic Targets in Adults with Type 1 Diabetes: Results from the DIAPANTHER Registry
Robert Bem, MD, PhD, MHA
Diabetes Cetnre, Institute of Clinical and Experimental Medicine
Prague, Czech Republic
13:55
Inpatient Outcomes and Resource Utilization in Diabetic Ketoacidosis Hospitalizations With and Without Insulin Pump Use: A National Inpatient Sample Analysis, 2016–2022
Meron Yafet Berhane, MD
Loyola Medicine MacNeal Hospital, Berwyn, IL, USA
14:05
A Temporally Constrained Bayesian Network Framework for Analyzing Glycemic Risk During Physical Activity in People with Type 1 Diabetes on Automated Insulin Delivery
Alberto Gastaldello, MSc
Department of Information Engineering, University of Padova
Padova, Italy
14:15
Q&A
Session 9B: Diabetes Center of Bern Innovation Challenge
No CE
Ema Grabenweger, MA
Diabetes Center Berne, Berne, Switzerland
Greta Ehlers, MS
Diabetes Center Berne, Berne, Switzerland
13:10
Introduction to DCB & Our Research Initiatives
13:25
About DCB Innovation Bootcamp
13:40
Adaptyx Bioscience (USA)
Alex Yoshikawa, Co-Founder & CSO
13:45
Alnu Health Connect (USA)
Jesse Kesner, Co-Founder
Max Elrad, Co-Founder
13:50
Insulinecho (Saudi Arabia)
Reem Jalal Alshareef, Founder
13:55
T1D1 (USA)
Drew Mendelow, Founder
Laura Mendelow, Executive Director (CEO)
14:00
ContextML UG (Germany)
Jens Lund, Co-Founder & CEO
Kate Snow, Co-Founder & Head of Product & Design
14:05
Q+A
BREAK
14:20
Session 10A: Abstracts 2
No CE
Sirimon Reutrakul, MD
Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois College of Medicine at Chicago, Chicago, IL, USA
Agatha Scheideman, BA
Diabetes Technology Society, Burlingame, CA, USA
14:50
Glycemic Control and Insulin Requirements Across Menstrual Cycle Phases in Type 1 Diabetes (DIAMENS): Real-World Insights from Continuous Glucose Monitoring and a Digital Health App
Omaima El-Hakouni, MSc
Medical University of Graz, Graz, Styria, Austria
15:00
Behavioral and Bedtime Treatment Predictors of Nocturnal Glycemia in Adults with Type 1 Diabetes Mellitus: A Retrospective Analysis of the OhioT1DM Dataset
Anusha Sultan Meo, MBBS, MPH
School of Health Sciences, National University of Sciences and Technology (NUST), Islamabad, Pakistan
15:10
The Role of Genetics, Epigenetics and Environment in the Pathophysiology of Type 2 Diabetes Mellitus
Sultan Ayoub Meo, MBBS, PhD
Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia
15:20
Real-World Effectiveness of the iLet® Bionic Pancreas in a Diverse Pediatric Population With Type 1 Diabetes
Elizabeth R. Sullivan-Ingram, DO
University of Alabama at Birmingham, Birmingham, AL, USA
15:30
The Effect of the MiniMed™ 780G (MM780G) Algorithm on Time with Rapid Glucose Change (TRC)
Robert Vigersky, MD
MiniMed, Inc., Northridge, CA, USA
15:40
Multicenter Best Practice Advisory to Improve Equitable Use of Automated Insulin Delivery Systems in Type 1 Diabetes
Risa Wolf, MD
Division of Pediatric Endocrinology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA
15:50
On-Demand AI as a Workout Partner: A Nurse-Built Digital Physical Activity Intervention Achieving 100% Completion in Older Adults Enrolled in a Medicare Diabetes Prevention Program
Gwendolyn Woody, LPN
The Nutritionist and Nurse | Copper and Greens, Houston, TX, USA
16:00
Noninvasive Glucose Monitoring using Band-pass Raman Spectroscopy
Jeon Woong Kang, PhD
MIT, Cambridge, MA, USA
16:10
Q&A
Session 10B: Hot Topics
1.5 CE
Kayo Waki, PhD
Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Marcos Matabuena, PhD
Mohamed bin Zayed University of Artificial Intelligence, Abu Dhabi, United Arab Emirates
14:50
The Need for Sustainability for Diabetes Devices
Lutz Heinemann, PhD
Science Consulting in Diabetes GmbH, Düsseldorf, Germany
15:05
Intra-arterial Measurement of Glucose
Simon Schwaighofer, MD
GlucoSet SA, Trondheim, Norway
15:20
Meals: When Matters as Much as What You Eat
Kong Chen, PhD
National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
15:35
SWEET Method for Assessing LLM Performance
Tao Wang, PhD
Stanford University, Palo Alto, CA, USA
15:50
NutriBench: A Dataset for Evaluating Large Language Models on Nutrition Estimation from Meal Descriptions
Yao Qin, PhD
University of California, Santa Barbara, Santa Barbara, CA, USA
16:05
Expanding Diabetes Digital Health Technologies (DHTs) for Prevention of Chronic Diseases
Zan Fleming, MD
Kinexum, Harpers Ferry, VA, USA
16:20
Q+A
Session 11: Live Demo
No CE
Dorian Liepmann, PhD
UC Berkeley, Berkeley, CA, USA
16:25
EEG Measurement of Glucose in Real Time
Emily Mirro, MBA
SynchNeuro, Inc, Philadelphia, PA, USA
Q+A
WRAP UP
16:40